DE1770731A1 - Neue blutzuckersenkende Sulfonamide - Google Patents

Neue blutzuckersenkende Sulfonamide

Info

Publication number
DE1770731A1
DE1770731A1 DE19681770731 DE1770731A DE1770731A1 DE 1770731 A1 DE1770731 A1 DE 1770731A1 DE 19681770731 DE19681770731 DE 19681770731 DE 1770731 A DE1770731 A DE 1770731A DE 1770731 A1 DE1770731 A1 DE 1770731A1
Authority
DE
Germany
Prior art keywords
general formula
carbonamido
meaning given
given above
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681770731
Other languages
German (de)
English (en)
Inventor
Klaus Dr Rer Nat Gutsche
Harald Dr Rer Nat Horstmann
Olaf Dr Med Vet Loge
Hans Dr Rer Nat Pluempe
Walter Dr Med Puls
Eberhard Dr Rer Nat Schroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19681770731 priority Critical patent/DE1770731A1/de
Priority to BR208777/69A priority patent/BR6908777D0/pt
Priority to DK300869AA priority patent/DK123602B/da
Priority to CH860269A priority patent/CH518968A/de
Priority to CH1669171A priority patent/CH518970A/de
Priority to CH1669271A priority patent/CH518971A/de
Priority to ES368100A priority patent/ES368100A1/es
Priority to IL32396A priority patent/IL32396A/xx
Priority to GB30406/69A priority patent/GB1268835A/en
Priority to AT573169A priority patent/AT289109B/de
Priority to AT788770A priority patent/AT291255B/de
Priority to AT788870A priority patent/AT291256B/de
Priority to SE08952/69A priority patent/SE357365B/xx
Priority to IE873/69A priority patent/IE33175B1/xx
Priority to NO2659/69A priority patent/NO124374B/no
Priority to FR696921467A priority patent/FR2014300B1/fr
Priority to NL6909960A priority patent/NL6909960A/xx
Priority to BE735287D priority patent/BE735287A/xx
Publication of DE1770731A1 publication Critical patent/DE1770731A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19681770731 1968-06-27 1968-06-27 Neue blutzuckersenkende Sulfonamide Pending DE1770731A1 (de)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DE19681770731 DE1770731A1 (de) 1968-06-27 1968-06-27 Neue blutzuckersenkende Sulfonamide
BR208777/69A BR6908777D0 (pt) 1968-06-27 1969-05-14 Processo para a preparacao de novas sulfonamidas
DK300869AA DK123602B (da) 1968-06-27 1969-06-03 Analogifremgangsmåde til fremstilling af sulfonamider.
CH860269A CH518968A (de) 1968-06-27 1969-06-05 Verfahren zur Herstellung von neuen Sulfonamiden
CH1669171A CH518970A (de) 1968-06-27 1969-06-05 Verfahren zur Herstellung neuer Sulfonamide
CH1669271A CH518971A (de) 1968-06-27 1969-06-05 Verfahren zur Herstellung neuer Sulfonamide
ES368100A ES368100A1 (es) 1968-06-27 1969-06-06 Procedimiento para la preparacion de nuevas sulfonamidas que reducen el azucar en la sangre.
IL32396A IL32396A (en) 1968-06-27 1969-06-13 Hypoglycemic benzene sulphonamido-2-pyrimidine derivatives
GB30406/69A GB1268835A (en) 1968-06-27 1969-06-16 New sulphonamides having a blood sugar lowering action
AT573169A AT289109B (de) 1968-06-27 1969-06-17 Verfahren zur Herstellung von neuen heterocyclischen Verbindungen und ihren Salzen
AT788770A AT291255B (de) 1968-06-27 1969-06-17 Verfahren zur Herstellung von neuen heterocyclischen Verbindungen und ihren Salzen
AT788870A AT291256B (de) 1968-06-27 1969-06-17 Verfahren zur Herstellung von neuen heterocyclischen Verbindungen und ihren Salzen
SE08952/69A SE357365B (xx) 1968-06-27 1969-06-24
IE873/69A IE33175B1 (en) 1968-06-27 1969-06-25 New sulphonamides having a blood sugar lowering action
NO2659/69A NO124374B (xx) 1968-06-27 1969-06-26
FR696921467A FR2014300B1 (xx) 1968-06-27 1969-06-26
NL6909960A NL6909960A (xx) 1968-06-27 1969-06-27
BE735287D BE735287A (xx) 1968-06-27 1969-06-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770731 DE1770731A1 (de) 1968-06-27 1968-06-27 Neue blutzuckersenkende Sulfonamide

Publications (1)

Publication Number Publication Date
DE1770731A1 true DE1770731A1 (de) 1971-11-25

Family

ID=5700618

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681770731 Pending DE1770731A1 (de) 1968-06-27 1968-06-27 Neue blutzuckersenkende Sulfonamide

Country Status (14)

Country Link
AT (3) AT289109B (xx)
BE (1) BE735287A (xx)
BR (1) BR6908777D0 (xx)
CH (1) CH518968A (xx)
DE (1) DE1770731A1 (xx)
DK (1) DK123602B (xx)
ES (1) ES368100A1 (xx)
FR (1) FR2014300B1 (xx)
GB (1) GB1268835A (xx)
IE (1) IE33175B1 (xx)
IL (1) IL32396A (xx)
NL (1) NL6909960A (xx)
NO (1) NO124374B (xx)
SE (1) SE357365B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2048906A1 (de) * 1970-10-06 1972-04-13 Boehringer Mannheim Gmbh, 6800 Mannheim Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
AU2003232551A1 (en) * 2002-06-13 2003-12-31 Qlt Inc. Methods of using isothiazole derivatives to treat cancer or inflammation

Also Published As

Publication number Publication date
AT291255B (de) 1971-07-12
NO124374B (xx) 1972-04-10
AT289109B (de) 1971-04-13
SE357365B (xx) 1973-06-25
GB1268835A (en) 1972-03-29
AT291256B (de) 1971-07-12
BR6908777D0 (pt) 1973-01-23
IE33175B1 (en) 1974-04-03
FR2014300A1 (xx) 1970-04-17
BE735287A (xx) 1969-12-29
CH518968A (de) 1972-02-15
ES368100A1 (es) 1971-05-01
DK123602B (da) 1972-07-10
IL32396A (en) 1972-06-28
IL32396A0 (en) 1969-08-27
FR2014300B1 (xx) 1973-01-12
IE33175L (en) 1969-12-27
NL6909960A (xx) 1969-12-30

Similar Documents

Publication Publication Date Title
DE2504252C2 (xx)
DE2516025C2 (xx)
DE3218584A1 (de) 1,2-diaminocyclobuten-3,4-dione, verfahren zu deren herstellung und pharmazeutische mittel, die diese verbindungen enthalten
EP0041215B1 (de) Imidazoazolalkensäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE1620450C3 (de) 1 - (2- Hydroxybenzyl) -2-piperazinomethylbenzimidazole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2352055A1 (de) Neue 2-oxazolinderivate und verfahren zur herstellung derselben
DE1445186B2 (de) 3,3'-Di-2-imidazolin-2-yl-carbanilid
DE2630060A1 (de) 2-brom-6-fluor-n-2-imidazolidinyliden- benzamin, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu dessen herstellung
DE2850948A1 (de) Pyridinderivat, verfahren zu seiner herstellung und arzneimittel
DE1129501B (de) Verfahren zur Herstellung von Sulfamylanthranilsaeuren
DE3438244C2 (xx)
DE1770731A1 (de) Neue blutzuckersenkende Sulfonamide
DE2000030C3 (de) 3-Alkoxy-und 3-Phenoxy-2-(diphenylhydroxy)methyl-propylamine und diese enthaltende Arzneimittel
DE1593728A1 (de) Verfahren zur Herstellung von substituierten Amidinen
DE3538063C2 (xx)
DE2425767A1 (de) 3-alkyl-9-aminoalkyl-1,2,3,4-tetrahydrocarbazole und ihre verwendung in arzneimitteln
EP0088323B1 (de) Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE2521347B2 (de) Hydroxylsubstituierte 2-Chlor- a -(tertbutylaminomethyD-benzylalkohole, Herstellungsverfahren und Arzneimittel
DE2140865B2 (de) 1 -Imidazolyl-methanphosphonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2046087A1 (de) Neue cycloaliphatische difunküonelle stickstoffhaltige Sulfonsäureester, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2623377A1 (de) 2-imidazoline und ihre anwendung in pharmazeutischen zubereitungen sowie verfahren zu ihrer herstellung
DE809077C (de) Verfahren zur Herstellung substituierter Isothioharnstoffe bzw. ihrer Salze
DE2801353C2 (de) 2-Imino-3-thiocarbamoyl-2H-chromene und Verfahren zu deren Herstellung
DE1595875C (de) Phenothiazine und Verfahren zu deren Herstellung
EP0110219A1 (de) Heterocyclisch substituierte Nitrile, ihre Herstellung und Verwendung als Arzneimittel